Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electrograms
Sponsor: Abbott Medical Devices
Listed as NCT02057588, this NA trial focuses on Arrythmia and remains completed. Sponsored by Abbott Medical Devices, it has been updated 11 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Apr 2021 — May 2022 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
Phase: PHASE3 → NA
-
May 2019 — May 2020 [monthly]
Recruiting PHASE3
-
Mar 2019 — May 2019 [monthly]
Recruiting PHASE3
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Feb 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
For direct contact, visit the study record on ClinicalTrials.gov .